AVANIR Pharmaceuticals (AVNR)
Create an Alert
4.655
+0.04 +0.87%
NASDAQ
Jun 19, 12:19PM
BATS Real time
Currency in USD
AVANIR Pharmaceuticals Net Interest Income Quarterly:
-1.044M for March 31, 2013AVANIR Pharmaceuticals Historical Net Interest Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -1.044M |
| Dec. 31, 2012 | -1.040M |
| Sept. 30, 2012 | -1.046M |
| June 30, 2012 | -0.3182M |
| March 31, 2012 | 0.0079M |
| Dec. 31, 2011 | 0.0143M |
| Sept. 30, 2011 | 0.0108M |
| June 30, 2011 | 0.0108M |
| March 31, 2011 | 0.0101M |
| Dec. 31, 2010 | 0.0071M |
| Sept. 30, 2010 | 0.0042M |
| June 30, 2010 | 0.0027M |
| March 31, 2010 | 0.0024M |
| Dec. 31, 2009 | 0.0058M |
| Sept. 30, 2009 | 0.0079M |
| June 30, 2009 | 0.0155M |
| March 31, 2009 | 0.0451M |
| Dec. 31, 2008 | 0.1352M |
| Sept. 30, 2008 | 0.2561M |
| June 30, 2008 | 0.2014M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Interest Income
Revenues from interest-bearing assets. A typical example would be interest earned by a bank on personal or commercial loans.
Learn More
AVNR Net Interest Income Quarterly Benchmarks
| Companies | |
|---|---|
| Catalyst Pharmaceutical Partners | 0.0096M |
| Galectin Therapeutics | 0.005M |
| Valeant Pharmaceuticals International | -153.72M |
AVNR Net Interest Income Quarterly Rankings
| Overall |
66th percentile 5660 of 16782 |
| Sector |
52nd percentile 676 of 1410 in Healthcare |
| Industry |
54th percentile 69 of 152 in Drug Manufacturers - Specialty & Generic |
AVNR Net Interest Income Quarterly Range, Past 5 Years
| Minimum | -1.046M | Sep 2012 |
| Maximum | 0.2561M | Sep 2008 |
| Average | -0.1356M |
